Dr Debra Patt: Consolidation and New Advanced Therapies in Oncology
March 25th 2023Debra Patt, MD, PhD, MBA, executive vice president at Texas Oncology, discusses financial drivers affecting community oncology as well as new advances within cancer care that allow it to be treated as a chronic disease.
Read More
Amy Valley Says Prior Authorization Needs to Be "Dramatically Changed"
March 24th 2023Amy Valley, vice president for Clinical Strategy and Technology Solutions at Cardinal Health, discusses challenges presented within the oncology community, and how Cardinal Health is addressing these issues.
Read More
Ben Jones: Collaboration Between CMMI, Providers, Practices Needed for EOM
March 24th 2023Ben Jones, vice president of Government Relations and Public Policy at the US Oncology Network, discussed the Enhancing Oncology Model (EOM), and why it's such an important topic at this year's conference.
Read More
Nicolas Ferreyros: There Is Growing Recognition the 340B Program Is "Out of Control"
March 22nd 2023Growing bipartisan awareness of issues with the 340B drug pricing program will hopefully lead to reform, says Nicolas Ferreyros, BA, managing director of policy, advocacy, and communications at the Community Oncology Alliance.
Read More
Nicolas Ferreyros: COA's 2023 Community Oncology Conference Celebrating 2 Decades of Achievements
March 16th 2023This year's Community Oncology Conference will celebrate 2 decades of achievements in community oncology and begin to chart a path forward for the future, said Nicolas Ferreyros, managing director of policy, advocacy, and communications at Community Oncology Alliance (COA).
Read More
Examining the Impact of Language Barriers, Ethnicity on Asthma Outcomes
March 12th 2023Abstracts presented at the American Academy of Allergy, Asthma & Immunology conference examined how ethnic and language barriers in respiratory care affect Hispanic patients, with results showing the need for improved asthma care.
Read More
Multiple Comorbid Conditions Identified as Risk Factors for Death in Severe COPD, Study Finds
March 10th 2023The prevalence of comorbidities in patients with severe chronic obstructive pulmonary disease (COPD), including impaired kidney function, are predictors of long-term mortality, study finds.
Read More
Integrating COPD Services Results in Improved Patient Care Delivery, Study Finds
March 9th 2023A combination of evidence-based interventions and team-based approaches shows efficacy in helping physicians care for patients with chronic obstructive pulmonary disease (COPD), according to one study.
Read More
Studies Presented at AAAAI Examine US Racial, Ethnic Disparities for Individuals With Asthma, Eczema
March 8th 2023How asthma and other skin conditions cluster in Black children and a finding of increased risk of respiratory infections in Black and Mexican-American children with asthma were among the studies presented at the American Academy of Allergy, Asthma, and Immunology (AAAAI) conference.
Read More
Dr Edward Boyer Speaks on Ohio Train Derailment: Exposure Risks, the Nocebo Effect
March 6th 2023Edward W. Boyer, MD, PhD, medical toxicologist, The Ohio State University, shares his thoughts on possible reasons why residents in East Palestine, Ohio, are reporting smelling chemicals, feeling ill, and developing rashes.
Read More
Dr Edward Boyer: Immediate and Long-term Respiratory Effects of the Ohio Train Derailment
March 2nd 2023Edward W. Boyer, MD, PhD, medical toxicologist, The Ohio State University, discusses respiratory health risks associated with chemical exposure after the train derailment in East Palestine, Ohio.
Read More